Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Dermata Therapeutics Inc’s stock clocked out at $1.26, down -7.35% from its previous closing price of $1.36. In other words, the price has decreased by -$7.35 from its previous closing price. On the day, 57845.0 shares were traded. DRMA stock price reached its highest trading level at $1.36 during the session, while it also had its lowest trading level at $1.26.
Ratios:
To gain a deeper understanding of DRMA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.44. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DRMA now has a Market Capitalization of 2571370 and an Enterprise Value of -3382398.
Stock Price History:
Over the past 52 weeks, DRMA has reached a high of $10.20, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is 1.21%, while the 200-Day Moving Average is calculated to be -51.08%.
Shares Statistics:
It appears that DRMA traded 317.92K shares on average per day over the past three months and 187780 shares per day over the past ten days. A total of 2.04M shares are outstanding, with a floating share count of 2.02M. Insiders hold about 0.84% of the company’s shares, while institutions hold 0.32% stake in the company. Shares short for DRMA as of 1730332800 were 93737 with a Short Ratio of 0.40, compared to 1727654400 on 69108. Therefore, it implies a Short% of Shares Outstanding of 93737 and a Short% of Float of 6.280000500000001.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
